New figure in UK international healthcare policy
This article was originally published in Clinica
The UK's Department of Health (DH) is setting up an International Health Advisory Board to support the chief medical officer in his role as advisor to the government on international health issues. Through a network of experts, the board will be relied upon to provide independent, expert advice; it will also seek to raise the profile of the DH's international health activities. Hamid Ghodse, director of the International Centre of Drug Policy, at the University of London's St George’s college, will be its inaugural chairperson. "Many of today’s health issues need to be considered in an international context and it is essential that the UK plays a full role in the relevant international forums, both learning from the experience of others and making an effective contribution," said Professor Ghodse.
You may also be interested in...
Vertex is hoping for EU approval in Q4 of its cystic fibrosis triple combination therapy, Trikafta. It wants the same licence in the EU as it has in the US, where the product has already become a best seller for the company.
Sawai’s sales increased on the back of a good performance from recently-launched products in the first nine months of its financial year. However, given the competitive environment the Japanese company is continuing to stick to its full-year forecasts.